Evaluation of adherence to drug treatment in patients with systemic lupus erythematosus in Brazil

被引:35
|
作者
Oliveira-Santos, M. [1 ,2 ]
Verani, J. F. S. [1 ]
Klumb, E. M. [2 ]
Albuquerque, E. M. N. [2 ]
机构
[1] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Dept Epidemiol & Metodos Quantitativos Saude, Rio De Janeiro, Brazil
[2] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, BR-20550011 Rio De Janeiro, Brazil
关键词
adherence to drug treatment; systemic lupus erythematosus; hierarchical multivariate analysis; RECOMMENDATIONS; MEDICATIONS; AMERICAN;
D O I
10.1177/0961203310383736
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objectives of this study were to measure the prevalence of adherence to drug treatment and analyze associations with characteristics pertaining to the treatment, disease, health professionals and services, and socio-demographic issues in patients with systemic lupus erythematosus (SLE) in the city of Rio de Janeiro, Brazil. A sample of 246 women with SLE was analyzed. The data were collected through individual interviews and a review of patient charts. Adherence was estimated according to the Morisk criteria, and the associated factors were analyzed by hierarchical modeling. The percentage of patients classified as adherent to treatment was 31.7%. The reasons cited for non-adherence were: carelessness with drug administration times (52.43%), forgetfulness (38.21%), adverse drug reaction (13.8%), and interruption of treatment due to improvement in symptoms (7.72%). Factors associated with adherence were: behavior towards the presence of adverse drug reaction, hematological alterations, presence of mucocutaneous manifestations, legibility of the medical prescription, schooling, and family support. The study concludes that adherence to drug treatment in SLE is a complex and multifactorial phenomenon, and the results corroborate findings from studies conducted in developed countries. The hierarchical modeling proved to be a good alternative for evaluating adherence, since it allowed visualizing the various stages in the analysis. Lupus (2011) 20, 320-329.
引用
收藏
页码:320 / 329
页数:10
相关论文
共 50 条
  • [21] Medication adherence is influenced by resilience in patients with systemic lupus erythematosus
    Mendoza-Pinto, Claudia
    Garcia-Carrasco, Mario
    Campos-Rivera, Sandra
    Munguia-Realpozo, Pamela
    Etchegaray-Morales, Ivet
    Ayon-Aguilar, Jorge
    Alonso-Garcia, Norma Edith
    Mendez-Martinez, Socorro
    LUPUS, 2021, 30 (07) : 1051 - 1057
  • [22] EVALUATION OF DEPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
    Soroceanu, A.
    Mazur, M.
    Darciuc, O.
    Soroceanu, S.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S68 - S68
  • [23] Drug Adherence Drug in Systemic Lupus Erythematosus Patients in Dr. Hasan Sadikin General Hospital Bandung
    Sheba, Shiane Hanako
    Djuhaeni, Henni
    Setiabudiawan, Budi
    Sunjaya, Deni K.
    Mutyara, Kuswandewi
    Rinawan, Fedri
    MAJALAH KEDOKTERAN BANDUNG-MKB-BANDUNG MEDICAL JOURNAL, 2018, 50 (01): : 21 - 28
  • [24] Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus
    Yang, Tzu-Han
    Wu, Tsai-Hung
    Chang, Yuh-Lih
    Liao, Hsien-Tzung
    Hsu, Chia-Chen
    Tsai, Chang-Youh
    Chou, Yueh-Ching
    CLINICAL NEPHROLOGY, 2018, 89 (04) : 277 - 285
  • [25] Determinants of adherence to therapy in systemic lupus erythematosus
    Pineau, Christian A.
    Da Costa, Deborah
    Bernatsky, Sasha
    Clarke, Ann E.
    Lee, Jennifer L.
    Rahme, Elham
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S809 - S809
  • [26] PREVALENCE OF CARDIOVASCULAR COMORBIDITIES AND ADHERENCE TO THERAPY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Popkova, Tatiana V.
    Panafidina, Tatiana A.
    Aristova, Maria
    Kondrateva, Liubov
    Gorbunova, Yulia N.
    CHEST, 2023, 164 (04) : 326A - 327A
  • [27] Concerns of patients with systemic lupus erythematosus and adherence to therapy - a qualitative study
    Farinha, Filipa
    Freitas, Francisco
    Agueda, Ana
    Cunha, Ines
    Barcelos, Anabela
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1213 - 1219
  • [28] Factors That Impact Medication Adherence in Hospitalized Patients with Systemic Lupus Erythematosus
    Jain, Prarthana
    Maheswaranathan, Mithu
    Mitchell, Holly
    Kamen, Diane
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2603 - 2604
  • [29] Evaluation of Lymphoproliferative Disorders in Patients with Systemic Lupus Erythematosus
    Lanjewar, Sonali
    Saad, Heba
    Parker, Kwabna
    Gupta, Raavi
    Haseeb, M. A.
    LABORATORY INVESTIGATION, 2017, 97 : 358A - 358A
  • [30] Evaluation of Lymphoproliferative Disorders in Patients with Systemic Lupus Erythematosus
    Lanjewar, Sonali
    Saad, Heba
    Parker, Kwabna
    Gupta, Raavi
    Haseeb, M. A.
    MODERN PATHOLOGY, 2017, 30 : 358A - 358A